German Distributor placed six-figure initial order that is expected to ship in the third quarter of 2024
Germany is the largest fitness market after the United States
Germany's largest fitness company, RSG Group, owns Gold's Gym and McFIT among other brands
The proposed transaction will create a Nasdaq-traded, biotechnology company with product candidates in advanced stages of clinical development and focused on advancing Kadimastem's allogeneic cell therapy platform
Each of Kadimastem and NLS Pharmaceutics has received commitments of support for the transaction from shareholders representing more than 40% of their respective outstanding shares
Read More
CLMBR is now an Approved Vendor Partner for Crunch Fitness franchisees, following a successful pilot at Crunch West Hollywood earlier this year
CLMBR is exhibiting at the Annual Crunch Franchise Convention, from July 28 to August 1 in Phoenix, AZ
There are more than 460 locations and 2.5 million members in the Crunch Fitness system
The clinical study of new potential VELDONA-based animal drug is poised to expand VELDONA's market.
This clinical trial aims to complete the enrollment of 30 subjects by the end-2024 with the trial report to be finalized in Q1 2025.
Read MoreInitial results of unprecedented trial including 10 different tumor types indicate that OnTarget did not meet its primary endpoint across all tumor types. Trial did reveal clinically relevant signals for crofelemer in prespecified subgroups of patients with breast and respiratory cancer, including lung cancer.
Jaguar to host investor webcast Tuesday, July 23rd at 8:30 AM Eastern to provide updates on company's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea (CTD) and oral mucositis; Click here to register for webcast.
Read More
Co-Founder and Co-Chairman of The Carlyle Group brings multi-industry investor experience and global policy expertise, replacing retiring director Stephen Berenson
Co-founder and director Robert Langer also to retire from the Moderna Board; recruitment efforts ongoing for his replacement
Read MoreBioTech Medics, Inc. (OTC PINK:BMCS) and its subsidiary Commodity Vault are pleased to announce that the firms have created the architecture for our RWA Tokenization Trading Platform that includes, tokens, various commodities, verified blockchains, white papers, apps, wallets, websites, stocks and strategic partnerships all of these components, and more encompass our ecosystem
Read MoreWebcast on Tuesday, July 23rd at 8:30 AM Eastern will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea (CTD) and oral mucositis; Click here to register for webcast
Jaguar expands Make Cancer Less Shitty (MCLS) patient advocacy program to incorporate select group of MCLS Ambassadors - cancer survivors who understand the realities of cancer and are no longer willing to accept debilitating side effects of cancer treatments as an acceptable trade-off for survival
Cancer patients with diarrhea are 40% more likely to discontinue their therapy; oral mucositis affects up to 40% of patients undergoing chemotherapy and approximately 90% of those receiving chemoradiation for head and neck cancers, with more than one-third of patients discontinuing cancer treatment because of the condition
Read More- STAR-1 topline results expected in first quarter of 2025 -
- About 30 million acne patients seek treatment in the U.S. each year -
- DMT310, if approved, could be the first once-weekly topical product for the treatment of acne -
Read MorePre-clinical study to explore use of MODD1 pump as a delivery system for FDA-approved, short acting peptides, as a personalized alternative for people who discontinue long-acting GLP-1 formulations
Read More
